Charles River Laboratories revenue growth has been varied year-over-year.

What is CRL's revenue growth rate?

Historical revenue data is available for Charles River Laboratories to analyze growth trends.

How fast is CRL earnings growing?

Earnings growth data is available for Charles River Laboratories analysis.

What is CRL's profit margin?

Profit margin data is available for Charles River Laboratories.

CRL Revenue & Earnings Growth Analysis 2026 - Is Charles River Laboratories Growing?

Growth Summary

Charles River Laboratories (CRL) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

Over the past 4 years, Charles River Laboratories has achieved a revenue compound annual growth rate (CAGR) of 50.4%, while earnings have grown at -48.7% CAGR.

Latest Revenue

$4.05B

Net Income

$25.29M

5-Year Revenue CAGR

50.4%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Charles River Laboratories

The chart above illustrates Charles River Laboratories's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Charles River Laboratories's business.

Profit Margin Trends

How efficiently Charles River Laboratories converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Charles River Laboratories retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$11.03

Current: $0.20

EPS Estimate 2027

$12.01

9.0% expected growth

Price Target

$197.20

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Charles River Laboratories to continue growing earnings in the coming year. The consensus analyst rating is 3.3158 based on 19 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, Charles River Laboratories (CRL) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 50.4% CAGR over 4 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Charles River Laboratories's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.